Author/Creator: Sood, Rajeev - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Sood, Rajeev

1. 1959. Ceftriaxone-Sulbactam-EDTA (CSE) vs. Meropenem (MR) in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes in Patients Infected With Ceftriaxone Non-Susceptible, Extended-Spectrum β-Lactamase and Multi-Drug-resistant Pathogens at Baseline. (26th November 2018)

Authors:: Mir, Mohd Amin; Chaudhary, Saransh; Mammen, Kim Jacob; Sood, Rajeev; Dogra, P N; Chadha, Sudhir; Mavuduru, Ravimohan; Sinha, Rahul Janak; Chaudhary, Manu; Shiekh, Gazalla
Journal:: Open forum infectious diseases
Issue:: Volume 5(2018)Supplement 1
Page Start:: S567
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis. (26th November 2018)

Authors:: Mandale, Pankaj; Mir, Mohd Amin; Chaudhary, Saransh; Chaudhary, Manu; Sood, Rajeev; Patil, N S; Narang, Salil; Pyasi, Anurag; Shameem, Mohammad
Journal:: Open forum infectious diseases
Issue:: Volume 5(2018)Supplement 1
Page Start:: S573
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial. (21st August 2019)

Authors:: Mir, Mohd Amin; Chaudhary, Saransh; Payasi, Anurag; Sood, Rajeev; Mavuduru, Ravimohan S; Shameem, Mohd
Journal:: Open forum infectious diseases
Issue:: Volume 6:Number 10(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. PD26-04 A RANDOMIZED STUDY TO COMPARE OUTCOMES OF INTRAVESICAL CHEMOHYPERTHERMIA WITH MITOMYCIN C VS INTRAVESICAL BCG FOR INTERMEDIATE AND HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC). (May 2022)

Authors:: Guleria, Karandeep; Sood, Rajeev; Goel, Hemant; Sharma, Umesh; Singla, Anurag
Journal:: Journal of urology
Issue:: Volume 207(2022)Supplement 5
Page Start:: e488
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Results of a randomized, double‐blind, parallel‐group, placebo‐ and active‐controlled, multicenter study of mirabegron, a β3‐adrenoceptor agonist, in patients with overactive bladder in Asia. Issue 7 (17th August 2014)

Authors:: Kuo, Hann‐Chorng; Lee, Kyu‐Sung; Na, Yanqun; Sood, Rajeev; Nakaji, Shigeru; Kubota, Yosuke; Kuroishi, Kentarou
Journal:: Neurourology and urodynamics
Issue:: Volume 34:Issue 7(2015:Sep.)
Page Start:: 685
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The correlation between erectile dysfunction and metabolic syndrome in an Indian population: A cross-sectional observational study. Issue 3 (3rd July 2019)

Authors:: Sood, Rajeev; Sharma, Dushiant; Goel, Hemant; Khattar, Nikhil; Kulshreshtha, Bindu; Singh, Kunal K.
Journal:: Arab journal of urology
Issue:: Volume 17:Issue 3(2019)
Page Start:: 221
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗